Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
Next >
Weight loss drug contender Zealand Pharma jumps 23% on trial results
June 21, 2024
Tags
Zealand Pharma A/S
Europe Markets
Pharmaceuticals
From
CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
June 18, 2024
Tags
Social issues
Health & Science
Labor economy
From
CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
June 17, 2024
Tags
Eli Lilly and Co
Health care industry
Alphabet Inc
From
CNBC.com News
European stocks set for muted open after European Central Bank cut
June 07, 2024
Tags
Novo Nordisk A/S
World Economy
Europe Markets
From
CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
May 30, 2024
Tags
Business News
Small Business Playbook
Health Insurance
From
CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
May 29, 2024
Tags
Breaking news
Pharmaceuticals
Business
From
CNBC.com News
Cramer's Lightning Round: Apple is a buy
May 28, 2024
Tags
T Rowe Price Group Inc
S&P 500
Mad Money
From
CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
May 27, 2024
Tags
stocks
Personal investing
Stock markets
From
CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
May 25, 2024
Tags
Teladoc Health Inc
Goldman Sachs Group Inc
Health & Science
From
CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
May 21, 2024
Tags
Healthy Returns
Science
Health care industry
From
CNBC.com News
AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines
May 21, 2024
Tags
Europe News
Novo Nordisk A/S
Health & Science
From
CNBC.com News
Hims & Hers Health adds compounded GLP-1 injections to weight loss program
May 20, 2024
Tags
Business News
Novo Nordisk A/S
Breaking News: Technology
From
CNBC.com News
Roche says weight loss drug shows promising results in early trial
May 16, 2024
Tags
Business News
Health & Science
Biotechnology
From
CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
May 14, 2024
Tags
Social issues
Novo Nordisk A/S
Biotech and Pharmaceuticals
From
CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
May 14, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Eli Lilly and Co
From
CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
May 07, 2024
Tags
Eli Lilly and Co
Health care industry
Apple Inc
From
CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
May 07, 2024
Tags
Health care industry
Viking Therapeutics Inc
Eli Lilly and Co
From
CNBC.com News
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
May 03, 2024
Tags
Business
Pharmaceuticals
Health & Science
From
CNBC.com News
Amgen scraps experimental weight loss pill, moves forward with injection
May 02, 2024
Tags
Business
Pharmaceuticals
Breaking news
From
CNBC.com News
Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double
May 02, 2024
Tags
Earnings
Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
April 30, 2024
Tags
Breaking news
Pharmaceuticals
Business
From
CNBC.com News
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.
April 24, 2024
Tags
Health care industry
Policy
Congress
From
CNBC.com News
More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says
April 24, 2024
Tags
Business News
Health & Science
Biotechnology
From
CNBC.com News
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
April 20, 2024
Tags
Breaking news
Morgan Stanley
Business News
From
CNBC.com News
Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says
April 17, 2024
Tags
Breaking news
Pharmaceuticals
Business
From
CNBC.com News
Eli Lilly’s Zepbound shows promise as a sleep apnea treatment in late-stage trials
April 17, 2024
Tags
Biotechnology
US: News
Companies
From
CNBC.com News
EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughts
April 12, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Eli Lilly and Co
From
CNBC.com News
Diabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trial
April 04, 2024
Tags
Sanofi SA
Business
Pharmaceuticals
From
CNBC.com News
Danone CEO downplays threat of weight loss drugs on food producers: 'We see ourselves as extremely complementary'
April 04, 2024
Tags
US: News
Health & Science
Novo Nordisk A/S
From
CNBC.com News
Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billion
April 03, 2024
Tags
AstraZeneca PLC
Novo Nordisk A/S
Biotech and Pharmaceuticals
From
CNBC.com News
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.